FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2080963040> ?p ?o ?g. }

• W2080963040 endingPage "197" @default.
• W2080963040 startingPage "186" @default.
• W2080963040 abstract "Objective: To evaluate the full range of alcohol treatment effectiveness, it is important to assess secondary nondrinking outcome dimensions in addition to primary alcohol consumption outcomes. Method: We used a large sample (n = 1,226) of alcohol-dependent participants entering the National Institute on Alcohol Abuse and Alcoholism-sponsored COMBINE (Combining Medications and Behavioral Interventions) Study, a multisite clinical trial of pharmacological (naltrexone [ReVia] and acamprosate [Campral]) and behavioral interventions, to examine the effects of specific treatment combinations on nondrinking functional outcomes. We assessed the outcomes at baseline and at the end of 16 weeks of alcohol treatment and again at the 26-week and/or 52-week postrandomization follow-ups. Results: (1) Drinking and secondary outcomes were significantly related, especially at the follow-up periods. A higher percentage of heavy drinking days, more drinks per drinking day, and lower percentage of days abstinent were associated with lower quality-of-life measures. (2) All nondrinking outcomes showed improvement at the end of 16 weeks of treatment and most maintained improvement over the 26-week and 52-week follow-ups. Only two measures returned to pretreatment levels at 52 weeks: percentage of days paid for work and physical health. Improvements of nondrinking outcomes remained even after adjusting for posttreatment heavy drinking status. (3) Although nondrinking outcomes showed overall improvement, specific pharmacological and behavioral treatment combinations were not differentially effective on specific secondary outcomes. Conclusions: In the current study, changes that resulted from treatment were multidimensional, and improvements in nondrinking outcomes reflected the overall significant improvement in drinking but they were not differentiated between treatment combination groups. Findings from this study support the importance of including secondary nondrinking outcomes in clinical alcohol-treatment trials. (J. Stud. Alcohol Drugs 70: 186-196, 2009)" @default.
• W2080963040 created "2016-06-24" @default.
• W2080963040 creator A5008037322 @default.
• W2080963040 creator A5015770889 @default.
• W2080963040 creator A5019451447 @default.
• W2080963040 creator A5049134071 @default.
• W2080963040 creator A5052596802 @default.
• W2080963040 creator A5075420771 @default.
• W2080963040 creator A5077256575 @default.
• W2080963040 date "2009-03-01" @default.
• W2080963040 modified "2023-10-14" @default.
• W2080963040 title "Alcohol Treatment Effects on Secondary Nondrinking Outcomes and Quality of Life: The COMBINE Study" @default.
• W2080963040 cites W1268369627 @default.
• W2080963040 cites W1966288345 @default.
• W2080963040 cites W1966460145 @default.
• W2080963040 cites W1977914858 @default.
• W2080963040 cites W1979388674 @default.
• W2080963040 cites W1982842837 @default.
• W2080963040 cites W1995605212 @default.
• W2080963040 cites W1996299251 @default.
• W2080963040 cites W2007900545 @default.
• W2080963040 cites W2009747355 @default.
• W2080963040 cites W2014972070 @default.
• W2080963040 cites W2019640879 @default.
• W2080963040 cites W2023940469 @default.
• W2080963040 cites W2027322661 @default.
• W2080963040 cites W2027709005 @default.
• W2080963040 cites W2032314874 @default.
• W2080963040 cites W2032913202 @default.
• W2080963040 cites W2037199885 @default.
• W2080963040 cites W2037377025 @default.
• W2080963040 cites W2038624604 @default.
• W2080963040 cites W2040256551 @default.
• W2080963040 cites W2049184549 @default.
• W2080963040 cites W2062496151 @default.
• W2080963040 cites W2068530297 @default.
• W2080963040 cites W2069996619 @default.
• W2080963040 cites W2080999468 @default.
• W2080963040 cites W2098820202 @default.
• W2080963040 cites W2099288706 @default.
• W2080963040 cites W2100702853 @default.
• W2080963040 cites W2101372918 @default.
• W2080963040 cites W2103575838 @default.
• W2080963040 cites W2145033322 @default.
• W2080963040 cites W2146836620 @default.
• W2080963040 cites W2155714099 @default.
• W2080963040 cites W2162642430 @default.
• W2080963040 cites W2164469157 @default.
• W2080963040 cites W2170443227 @default.
• W2080963040 cites W2493727448 @default.
• W2080963040 cites W2903333993 @default.
• W2080963040 cites W564492501 @default.
• W2080963040 doi "https://doi.org/10.15288/jsad.2009.70.186" @default.
• W2080963040 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2653605" @default.
• W2080963040 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19261230" @default.
• W2080963040 hasPublicationYear "2009" @default.
• W2080963040 type Work @default.
• W2080963040 sameAs 2080963040 @default.
• W2080963040 citedByCount "41" @default.
• W2080963040 countsByYear W20809630402012 @default.
• W2080963040 countsByYear W20809630402013 @default.
• W2080963040 countsByYear W20809630402014 @default.
• W2080963040 countsByYear W20809630402015 @default.
• W2080963040 countsByYear W20809630402016 @default.
• W2080963040 countsByYear W20809630402017 @default.
• W2080963040 countsByYear W20809630402018 @default.
• W2080963040 countsByYear W20809630402019 @default.
• W2080963040 countsByYear W20809630402020 @default.
• W2080963040 countsByYear W20809630402021 @default.
• W2080963040 countsByYear W20809630402022 @default.
• W2080963040 countsByYear W20809630402023 @default.
• W2080963040 crossrefType "journal-article" @default.
• W2080963040 hasAuthorship W2080963040A5008037322 @default.
• W2080963040 hasAuthorship W2080963040A5015770889 @default.
• W2080963040 hasAuthorship W2080963040A5019451447 @default.
• W2080963040 hasAuthorship W2080963040A5049134071 @default.
• W2080963040 hasAuthorship W2080963040A5052596802 @default.
• W2080963040 hasAuthorship W2080963040A5075420771 @default.
• W2080963040 hasAuthorship W2080963040A5077256575 @default.
• W2080963040 hasBestOaLocation W20809630402 @default.
• W2080963040 hasConcept C118552586 @default.
• W2080963040 hasConcept C126322002 @default.
• W2080963040 hasConcept C159110408 @default.
• W2080963040 hasConcept C168563851 @default.
• W2080963040 hasConcept C170493617 @default.
• W2080963040 hasConcept C185592680 @default.
• W2080963040 hasConcept C27415008 @default.
• W2080963040 hasConcept C2777972943 @default.
• W2080963040 hasConcept C2779442783 @default.
• W2080963040 hasConcept C2779951463 @default.
• W2080963040 hasConcept C2779992327 @default.
• W2080963040 hasConcept C2780931562 @default.
• W2080963040 hasConcept C2781063702 @default.
• W2080963040 hasConcept C2781066024 @default.
• W2080963040 hasConcept C3019635848 @default.
• W2080963040 hasConcept C55493867 @default.
• W2080963040 hasConcept C71924100 @default.
• W2080963040 hasConceptScore W2080963040C118552586 @default.

• next